KEGG   PATHWAY: nasi05161
Entry
nasi05161                   Pathway                                
Name
Hepatitis B - Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise)
Description
Hepatitis B virus (HBV) is an enveloped virus and contains a partially double-stranded relaxed circular DNA (RC-DNA) genome. After entry into hepatocytes, HBV RC-DNA is transported to the nucleus and converted into a covalently closed circular molecule cccDNA. The cccDNA is the template for transcription of all viral RNAs including the pregenomic RNA (pgRNA), encoding for 7 viral proteins: large, middle, and small envelope proteins (LHBs, MHBs, and SHBs) that form the surface antigen (HBsAg), the core antigen (HBcAg), the e antigen (HBeAg), the HBV polymerase, and the regulatory protein X (HBx). The pgRNA interacts with the viral polymerase protein to initiate the encapsidation into the core particles. Through endoplasmic reticulum, the core particles finish assembling with the envelope proteins and are released. HBV infection leads to a wide spectrum of liver diseases raging from chronic hepatitis, cirrhosis to hepatocellular carcinoma. The mechanism of liver injury is still not clear. However, HBV proteins target host proteins, involved in a variety of functions, thus regulating transcription, cellular signaling cascades, proliferation, differentiation, and apoptosis.
Class
Human Diseases; Infectious disease: viral
Pathway map
nasi05161  Hepatitis B
nasi05161

Organism
Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise) [GN:nasi]
Gene
112414377  HSPG2; basement membrane-specific heparan sulfate proteoglycan core protein [KO:K06255]
112396111  SLC10A1; sodium/bile acid cotransporter [KO:K14341]
112415266  TGFB1; transforming growth factor beta-1 isoform X1 [KO:K13375]
112395811  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
112394874  TGFB3; transforming growth factor beta-3 [KO:K13377]
112392633  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
112398737  TGFBR2; TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
112393136  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
112414074  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
112395723  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
112412478  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
112413113  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
112397143  MYC; myc proto-oncogene protein isoform X1 [KO:K04377]
112413294  EGR2; E3 SUMO-protein ligase EGR2 [KO:K12496]
112401465  EGR3; early growth response protein 3 [KO:K12497]
112409521  CREBBP; CREB-binding protein [KO:K04498] [EC:2.3.1.48]
112394621  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
112391613  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
112402257  DDB1; DNA damage-binding protein 1 [KO:K10610]
112402084  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
112413424  MAP3K1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]
112407323  YWHAZ; 14-3-3 protein zeta/delta [KO:K16197]
112400835  YWHAB; 14-3-3 protein beta/alpha [KO:K16197]
112394793  YWHAQ; 14-3-3 protein theta [KO:K16197]
112407567  14-3-3 protein theta [KO:K16197]
112404578  MAP2K4; dual specificity mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
112402798  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
112403325  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
112406349  PIK3CA; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
112404930  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
112400438  phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
112414874  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
112405757  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
112408453  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
112415459  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
112392983  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
112413114  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
112400454  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
112411167  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
112393728  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
112402272  RELA; transcription factor p65 [KO:K04735]
112400878  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
112406137  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
112402326  BAD; bcl2-associated agonist of cell death [KO:K02158]
112399577  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
112402377  FADD; FAS-associated death domain protein [KO:K02373]
112407903  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
112407867  CASP10; caspase-10 [KO:K04400] [EC:3.4.22.63]
112415661  BAX; apoptosis regulator BAX [KO:K02159]
112409026  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
112409526  cytochrome c-like [KO:K08738]
112396438  cytochrome c-like [KO:K08738]
112403640  LOW QUALITY PROTEIN: cytochrome c-like [KO:K08738]
112406320  cytochrome c [KO:K08738]
112414113  LOW QUALITY PROTEIN: cytochrome c-like [KO:K08738]
112394162  cytochrome c-like [KO:K08738]
112391536  cytochrome c 2 [KO:K08738]
112402819  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
112409662  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
112415739  LOW QUALITY PROTEIN: caspase-12-like [KO:K04741] [EC:3.4.22.-]
112410443  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
112404902  LOW QUALITY PROTEIN: baculoviral IAP repeat-containing protein 5-like [KO:K08731]
112401891  TP53; cellular tumor antigen p53 [KO:K04451]
112399757  CCNA2; cyclin-A2 [KO:K06627]
112406608  CCNA1; cyclin-A1 [KO:K06627]
112394072  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
112407307  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
112392336  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
112406557  RB1; retinoblastoma-associated protein [KO:K06618]
112398484  E2F1; transcription factor E2F1 [KO:K17454]
112414298  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
112396632  E2F3; transcription factor E2F3 [KO:K06620]
112400449  ATP6AP1; V-type proton ATPase subunit S1 [KO:K03662]
112410312  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
112399411  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
112397907  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
112406136  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
112403017  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
112392227  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
112405045  NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 isoform X1 [KO:K17334]
112395421  TNF; tumor necrosis factor [KO:K03156]
112412959  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
112392497  JAK2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
112414751  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
112400181  TYK2; non-receptor tyrosine-protein kinase TYK2 isoform X1 [KO:K11219] [EC:2.7.10.2]
112399936  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
112392137  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
112394097  STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
112392136  STAT4; signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
112399148  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]
112399174  signal transducer and activator of transcription 5B [KO:K11224]
112394079  STAT6; signal transducer and activator of transcription 6 isoform X1 [KO:K11225]
112413211  VDAC3; voltage-dependent anion-selective channel protein 3 [KO:K15041]
112391027  LOW QUALITY PROTEIN: voltage-dependent anion-selective channel protein 3-like [KO:K15041]
112414976  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
112398489  SRC; proto-oncogene tyrosine-protein kinase Src [KO:K05704] [EC:2.7.10.2]
112410317  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
112405189  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
112391586  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
112402519  HRAS; GTPase HRas isoform X1 [KO:K02833]
112391643  KRAS; GTPase KRas isoform X1 [KO:K07827]
112413065  NRAS; GTPase NRas [KO:K07828]
112407080  JUN; LOW QUALITY PROTEIN: transcription factor AP-1 [KO:K04448]
112407459  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
112391502  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
112395221  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
112402296  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
112397455  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
112411704  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
112400124  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 [KO:K09048]
112401787  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
112394733  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
112406282  CREB5; cyclic AMP-responsive element-binding protein 5 [KO:K09047]
112395436  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta [KO:K09049]
112405659  CXCL8; interleukin-8 [KO:K10030]
112412540  PCNA; LOW QUALITY PROTEIN: proliferating cell nuclear antigen [KO:K04802]
112402589  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
112398096  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
112407243  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
112393112  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
112400165  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
112412232  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
112399342  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
112394907  FOS; proto-oncogene c-Fos [KO:K04379]
112402600  ELK1; ETS domain-containing protein Elk-1 isoform X1 [KO:K04375]
112407985  TLR2; toll-like receptor 2 [KO:K10159]
112407416  MYD88; myeloid differentiation primary response protein MyD88 [KO:K04729]
112396829  TIRAP; toll/interleukin-1 receptor domain-containing adapter protein [KO:K05403]
112411200  TLR4; toll-like receptor 4 isoform X1 [KO:K10160]
112396652  IRAK4; interleukin-1 receptor-associated kinase 4 isoform X1 [KO:K04733] [EC:2.7.11.1]
112406760  IRAK1; interleukin-1 receptor-associated kinase 1 [KO:K04730] [EC:2.7.11.1]
112404544  TRAF6; TNF receptor-associated factor 6 isoform X1 [KO:K03175] [EC:2.3.2.27]
112410769  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform X1 [KO:K04403]
112401606  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
112390747  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
112395338  IL6; interleukin-6 [KO:K05405]
112404892  MAP2K3; dual specificity mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
112410464  MAP2K6; dual specificity mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
112413792  MAPK14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
112413934  MAPK13; mitogen-activated protein kinase 13 isoform X1 [KO:K04441] [EC:2.7.11.24]
112394646  MAPK12; mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
112394700  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
112400298  MAP2K7; dual specificity mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
112398647  TICAM2; TIR domain-containing adapter molecule 2 [KO:K05409]
112409663  TLR3; toll-like receptor 3 isoform X1 [KO:K05401]
112400342  TICAM1; TIR domain-containing adapter molecule 1 [KO:K05842]
112393613  IFIH1; interferon-induced helicase C domain-containing protein 1 [KO:K12647] [EC:5.6.2.6]
112398436  MAVS; mitochondrial antiviral-signaling protein isoform X1 [KO:K12648]
112408757  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
112403510  IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1 [KO:K07211] [EC:2.7.11.10]
112394248  TBK1; serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
112396076  ATP-dependent RNA helicase DDX3X-like [KO:K11594] [EC:5.6.2.7]
112409625  DDX3X; ATP-dependent RNA helicase DDX3X isoform X1 [KO:K11594] [EC:5.6.2.7]
112415465  IRF3; interferon regulatory factor 3 [KO:K05411]
112402386  IRF7; interferon regulatory factor 7 [KO:K09447]
112407025  interferon alpha-1-like [KO:K05414]
112395020  interferon alpha-1-like [KO:K05414]
112395023  interferon alpha-1-like [KO:K05414]
112395027  interferon alpha-1-like [KO:K05414]
112407026  IFNB1; interferon beta [KO:K05415]
112408548  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
Compound
C00076  Calcium cation
Reference
  Authors
Caballero A, Tabernero D, Buti M, Rodriguez-Frias F
  Title
Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy.
  Journal
Antiviral Res 158:34-44 (2018)
DOI:10.1016/j.antiviral.2018.07.019
Reference
  Authors
Walsh R, Locarnini S
  Title
Hepatitis B precore protein: pathogenic potential and therapeutic promise.
  Journal
Yonsei Med J 53:875-85 (2012)
DOI:10.3349/ymj.2012.53.5.875
Reference
  Authors
Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS
  Title
Present and future therapies of hepatitis B: From discovery to cure.
  Journal
Hepatology 62:1893-908 (2015)
DOI:10.1002/hep.28025
Reference
  Authors
Morikawa K, Suda G, Sakamoto N
  Title
Viral life cycle of hepatitis B virus: Host factors and druggable targets.
  Journal
Hepatol Res 46:871-7 (2016)
DOI:10.1111/hepr.12650
Reference
  Authors
Feitelson MA, Reis HM, Tufan NL, Sun B, Pan J, Lian Z
  Title
Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.
  Journal
Cancer Lett 286:69-79 (2009)
DOI:10.1016/j.canlet.2008.12.010
Reference
  Authors
Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K
  Title
Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
  Journal
Hepatology 49:1203-17 (2009)
DOI:10.1002/hep.22765
Reference
  Authors
Yoo YG, Lee MO
  Title
Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
  Journal
J Biol Chem 279:36242-9 (2004)
DOI:10.1074/jbc.M401290200
Reference
  Authors
Zhang X, Zhang H, Ye L
  Title
Effects of hepatitis B virus X protein on the development of liver cancer.
  Journal
J Lab Clin Med 147:58-66 (2006)
DOI:10.1016/j.lab.2005.10.003
Reference
  Authors
Benhenda S, Cougot D, Buendia MA, Neuveut C
  Title
Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.
  Journal
Adv Cancer Res 103:75-109 (2009)
DOI:10.1016/S0065-230X(09)03004-8
Reference
  Authors
Benhenda S, Cougot D, Neuveut C, Buendia MA
  Title
Liver cell transformation in chronic HBV infection.
  Journal
Viruses 1:630-46 (2009)
DOI:10.3390/v1030630
Reference
  Authors
Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD
  Title
X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.
  Journal
J Biol Chem 276:8328-40 (2001)
DOI:10.1074/jbc.M006026200
Reference
  Authors
Park NH, Song IH, Chung YH
  Title
Chronic hepatitis B in hepatocarcinogenesis.
  Journal
Postgrad Med J 82:507-15 (2006)
DOI:10.1136/pgmj.2006.047431
Reference
  Authors
Lin S, Zhang YJ
  Title
Interference of Apoptosis by Hepatitis B Virus.
  Journal
Viruses 9:E230 (2017)
DOI:10.3390/v9080230
Reference
  Authors
Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L
  Title
Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
  Journal
J Med Virol 77:374-81 (2005)
DOI:10.1002/jmv.20466
Reference
  Authors
Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn JK
  Title
Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria.
  Journal
IUBMB Life 60:473-80 (2008)
DOI:10.1002/iub.68
Reference
  Authors
Ng SA, Lee C
  Title
Hepatitis B virus X gene and hepatocarcinogenesis.
  Journal
J Gastroenterol 46:974-90 (2011)
DOI:10.1007/s00535-011-0415-9
Reference
PMID:9195957
  Authors
Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E
  Title
The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein.
  Journal
J Biol Chem 272:16482-9 (1997)
DOI:10.1074/jbc.272.26.16482
Reference
  Authors
Panteva M, Korkaya H, Jameel S
  Title
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
  Journal
Virus Res 92:131-40 (2003)
DOI:10.1016/S0168-1702(02)00356-8
Reference
PMID:9738022
  Authors
Lee YH, Yun Y
  Title
HBx protein of hepatitis B virus activates Jak1-STAT signaling.
  Journal
J Biol Chem 273:25510-5 (1998)
DOI:10.1074/jbc.273.39.25510
Reference
  Authors
Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ
  Title
Viral hepatocarcinogenesis: from infection to cancer.
  Journal
Liver Int 28:175-88 (2008)
DOI:10.1111/j.1478-3231.2007.01652.x
Reference
  Authors
Chami M, Oules B, Paterlini-Brechot P
  Title
Cytobiological consequences of calcium-signaling alterations induced by human viral proteins.
  Journal
Biochim Biophys Acta 1763:1344-62 (2006)
DOI:10.1016/j.bbamcr.2006.09.025
Reference
  Authors
Ganem D
  Title
Virology. The X files--one step closer to closure.
  Journal
Science 294:2299-300 (2001)
DOI:10.1126/science.1067850
Reference
  Authors
Chung TW, Lee YC, Kim CH
  Title
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
  Journal
FASEB J 18:1123-5 (2004)
DOI:10.1096/fj.03-1429fje
Reference
  Authors
Gurtsevitch VE
  Title
Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
  Journal
Biochemistry (Mosc) 73:504-13 (2008)
DOI:10.1134/S0006297908050039
Reference
  Authors
Schadler S, Hildt E
  Title
HBV life cycle: entry and morphogenesis.
  Journal
Viruses 1:185-209 (2009)
DOI:10.3390/v1020185
Reference
  Authors
Ortega-Prieto AM, Dorner M
  Title
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.
  Journal
Vaccines (Basel) 5:E24 (2017)
DOI:10.3390/vaccines5030024
Reference
  Authors
Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM, Arababadi MK
  Title
Innate immunity related pathogen recognition receptors and chronic hepatitis B infection.
  Journal
Mol Immunol 90:64-73 (2017)
DOI:10.1016/j.molimm.2017.07.002
Reference
  Authors
Bagheri V, Askari A, Arababadi MK, Kennedy D
  Title
Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
  Journal
Hum Immunol 75:549-54 (2014)
DOI:10.1016/j.humimm.2014.02.018
Reference
  Authors
Zhang E, Lu M
  Title
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
  Journal
Med Microbiol Immunol 204:11-20 (2015)
DOI:10.1007/s00430-014-0370-1
Reference
  Authors
Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z
  Title
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
  Journal
J Gen Virol 91:2080-90 (2010)
DOI:10.1099/vir.0.020552-0
Reference
  Authors
Revill P, Yuan Z
  Title
New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.
  Journal
Antivir Ther 18:1-15 (2013)
DOI:10.3851/IMP2542
Reference
  Authors
Hopcraft SE, Damania B
  Title
Tumour viruses and innate immunity.
  Journal
Philos Trans R Soc Lond B Biol Sci 372:20160267 (2017)
DOI:10.1098/rstb.2016.0267
Reference
  Authors
Dandri M, Locarnini S
  Title
New insight in the pathobiology of hepatitis B virus infection.
  Journal
Gut 61 Suppl 1:i6-17 (2012)
DOI:10.1136/gutjnl-2012-302056
Related
pathway
nasi04010  MAPK signaling pathway
nasi04064  NF-kappa B signaling pathway
nasi04110  Cell cycle
nasi04115  p53 signaling pathway
nasi04151  PI3K-Akt signaling pathway
nasi04210  Apoptosis
nasi04620  Toll-like receptor signaling pathway
nasi04622  RIG-I-like receptor signaling pathway
nasi04630  JAK-STAT signaling pathway
KO pathway
ko05161   
LinkDB

DBGET integrated database retrieval system